PUTRAJAYA:Anti-virus medicines such as remdesivir were found to be ineffective in treating COVID-19 patients as well as not helpful in reducing death cases of the outbreak.
Health director-general, Tan Sri Dr Noor Hisham Abdullah said clinical studies by the WHO Solidarity trial proved anti-malaria medicine hydroxychloroquine, as well as lopinavir and ritonavir were not effective in treating the disease.
"So we could conclude that remdesivir is not effective for us to treat COVID-19 patients in three aspects, namely death, admission to hospital and need for ventilator.
"Earlier we have no strong evidence, but today we have conducted studies not only in Malaysia but also involving countries under WHO," he told a media conference on the latest COVID-19 development today.
Earlier, all the medicines (remdesivir, hydroxychloroquine, lopinavir and ritonavir) were used to treat COVID-19 patients.
However, Dr Noor Hisham said anti-virus medicine, dexamethasone which could prevent pneumonia was found effective and gave positive results on the health of patients.
He said the clinical study involved COVID-19 patients from 30 countries including Malaysia.
On the procurement of vaccine, Dr Noor Hisham said MOH needed to look at the data on the effectiveness of the vaccine as well as study on its side effects before recommending its application for Malaysians,
"We need to see the effectiveness of vaccine and its complications if it is high...we have an issue to use the vaccine as safety is very important to MOH," he said.
Commenting on the involvement of Malaysia in COVID-19 Vaccine Global Access (COVAX) in developing the vaccine, Dr Noor Hisham said MOH agreed to be in the group as Malaysia could discuss with the company and countries to procure the vaccine.
Via COVAX, he said Malaysia is free to hold discussions with the countries or the company producing the vaccine.
"Apart from that, several issues should be studied in obtaining the vaccine such as why the price is already fixed when it is still not ready. MOH needs to take the responsibility and not the manufacturing company of the vaccine," he said and added that the issue should be further looked into.
-- BERNAMA
Bernama
Mon Oct 19 2020
Dr Noor Hisham said MOH needed to look at the data on the effectiveness of the vaccine as well as study on its side effects before recommending its application for Malaysians.
Lebih 840,000 permohonan untuk London Marathon 2025 pecah rekod dunia
Jumlah permohonan untuk menyertai larian TCS London Marathon tahun depan telah memecahkan rekod dunia.
WEF: Anwar jumpa 50 pemimpin industri & perniagaan, yakin pelabur bernilai tinggi pilih Malaysia
Datuk Seri Anwar Ibrahim menzahirkan keyakinan lebih banyak pelabur bernilai tinggi akan memilih Malaysia sebagai destinasi pelaburan mengikut jejak langkah syarikat-syarikat gergasi seperti Tesla, AWS, Infineon dan Nvidia.
AWANI Ringkas: Ikut jejak syarikat gergasi lain
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
Bursa Malaysia dibuka tinggi seiring prestasi Wall Street
Bursa Malaysia dibuka rendah pada Isnin, mengambil petunjuk pasaran serantau dan kenaikan di Wall Street pada hari Jumaat.
Kementerian Perpaduan kaji keperluan pelan tindakan pendidikan & penghargaan Rukun Negara
Kementerian Perpaduan Negara melalui Jabatan Perpaduan dan Integrasi Nasional akan mengkaji keperluan untuk melancarkan Pelan Tindakan Pendidikan & Penghargaan Rukun Negara sejajar dengan Dasar Perpaduan Negara 2021-2030.
Akta pekerjaan bagi lindungi pekerja OKU/Autistik diperlukan
Beatrice yang juga merupakan individu autistik berkata, bagi mengadakan akta atau menggubal dasar berkaitan, kerajaan perlu libatkan lebih banyak golongan autistik sebagai pemegang taruh utama.
Mesyuarat FOMC: The Fed dijangka kekalkan kadar faedah Mei 2024
Ketua Ekonomi Bank Muamalat Malaysia Bhd, Dr Mohd Afzanizam Abdul Rashid berkata, ia selepas unjuran awal beberapa pakar ekonomi melihat The Fed masih belum cukup yakin dengan usaha menurunkan kadar inflasi di negara itu.
Apple perkenal HomePod, HomePod Mini di Malaysia, harga bermula RM529
Kedua-duanya akan mula dijual 10 Mei 2024 untuk pasaran tempatan.
[TERKINI] Chegu Bard didakwa keluar kenyataan fitnah, menghasut
Ahli Jawatankuasa Penerangan Bersatu Badrul Hisham Shaharin atau dikenali ramai dengan nama panggilan Chegu Bard didakwa di Mahkamah Sesyen di sini hari ini atas dua pertuduhan menghasut dan mengeluarkan kenyataan fitnah yang akan merosakkan nama baik Yang di-Pertuan Agong Sultan Ibrahim.
WEF: TotalEnergies setuju tingkat pelaburan di Malaysia - PM
TotalEnergies menyatakan komitmen dan bersetuju untuk mempertingkatkan pelaburan dalam sektor huluan minyak dan gas serta terus meneroka peluang dalam bidang penyimpanan karbon di Malaysia.
Nippon Paint sumbang 1,000 liter cat anti-virus dan anti-bakteria kepada Hospital Sungai Buloh
Datin Wong Meng Lee memaklumkan sumbangan Nippon Paint VirusGuard itu merupakan tanda penghargaan atas dedikasi dan usaha barisan hadapan berdepan saat yang sukar ini.
Nak Zoom ke tak nak Zoom? Selamatkah duit saya dalam bank?
Jangkitan virus di komputer sama seperti jangkitan COVID-19 kepada manusia, semua bergantung kepada sikap seseorang itu sendiri.
Kombinasi kejuruteraan sosial & anti-virus perlu untuk atasi Zeus
Kejuruteraan sosial mengenai keselamatan dalam penggunaan internet serta perisian anti-virus yang dikemas kini perlu untuk atasi Zeus.